advertisement
Le R 19
Showing records 1 to 19 |
Display all abstracts from Le R123440 Acute angle-closure glaucoma before, during, and after the outbreak of COVID-19 in ChinaMao Y
Heliyon 2024; 10: e38404
121876 Efficacy and safety of penetrating canaloplasty versus ab externo canaloplasty for primary open-angle glaucoma: A randomized controlled trialYe W
Acta Ophthalmologica 2025; 103: e58-e65
123440 Acute angle-closure glaucoma before, during, and after the outbreak of COVID-19 in ChinaXie Y
Heliyon 2024; 10: e38404
121876 Efficacy and safety of penetrating canaloplasty versus ab externo canaloplasty for primary open-angle glaucoma: A randomized controlled trialLi J
Acta Ophthalmologica 2025; 103: e58-e65
123440 Acute angle-closure glaucoma before, during, and after the outbreak of COVID-19 in ChinaLi G
Heliyon 2024; 10: e38404
121876 Efficacy and safety of penetrating canaloplasty versus ab externo canaloplasty for primary open-angle glaucoma: A randomized controlled trialZhang S
Acta Ophthalmologica 2025; 103: e58-e65
123440 Acute angle-closure glaucoma before, during, and after the outbreak of COVID-19 in ChinaLe R
Heliyon 2024; 10: e38404
121876 Efficacy and safety of penetrating canaloplasty versus ab externo canaloplasty for primary open-angle glaucoma: A randomized controlled trialZhu S
Acta Ophthalmologica 2025; 103: e58-e65
123440 Acute angle-closure glaucoma before, during, and after the outbreak of COVID-19 in ChinaXu S
Heliyon 2024; 10: e38404
121876 Efficacy and safety of penetrating canaloplasty versus ab externo canaloplasty for primary open-angle glaucoma: A randomized controlled trialXie Y
Acta Ophthalmologica 2025; 103: e58-e65
123440 Acute angle-closure glaucoma before, during, and after the outbreak of COVID-19 in ChinaWang P
Heliyon 2024; 10: e38404
121876 Efficacy and safety of penetrating canaloplasty versus ab externo canaloplasty for primary open-angle glaucoma: A randomized controlled trialLe R; Zhou W
Acta Ophthalmologica 2025; 103: e58-e65
123440 Acute angle-closure glaucoma before, during, and after the outbreak of COVID-19 in ChinaWang X
Heliyon 2024; 10: e38404
121876 Efficacy and safety of penetrating canaloplasty versus ab externo canaloplasty for primary open-angle glaucoma: A randomized controlled trialHe M
Acta Ophthalmologica 2025; 103: e58-e65
123440 Acute angle-closure glaucoma before, during, and after the outbreak of COVID-19 in ChinaZhang Q
Heliyon 2024; 10: e38404
121876 Efficacy and safety of penetrating canaloplasty versus ab externo canaloplasty for primary open-angle glaucoma: A randomized controlled trialWang N
Acta Ophthalmologica 2025; 103: e58-e65
123440 Acute angle-closure glaucoma before, during, and after the outbreak of COVID-19 in ChinaZhang S
Heliyon 2024; 10: e38404
121876 Efficacy and safety of penetrating canaloplasty versus ab externo canaloplasty for primary open-angle glaucoma: A randomized controlled trialLiang Y
Acta Ophthalmologica 2025; 103: e58-e65
123440 Acute angle-closure glaucoma before, during, and after the outbreak of COVID-19 in ChinaLiang Y
Heliyon 2024; 10: e38404
Issue 25-1
Change Issue
advertisement